GLP-1R agonists are not a quick fix for weight lossBMJ 2012; 344 doi: http://dx.doi.org/10.1136/bmj.e1455 (Published 28 February 2012) Cite this as: BMJ 2012;344:e1455
- Kristen A Iverson, medical student1
- 1University of Manchester, Manchester M13 9PL, UK
I query the validity of Vilsbøll and colleagues’ statement, “traditional treatments for obesity are, unfortunately, often short lived and consequently not especially effective,” when glucagon-like peptide-1 receptor (GLP-1R) agonists have not yet been proved to be any better.1 No studies in their meta-analysis compared the use of GLP-1R agonists with …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial